Sarepta Therapeutics, Inc. (SRPT)
22.50
-0.49
(-2.13%)
USD |
NASDAQ |
Sep 04, 16:00
22.50
0.00 (0.00%)
After-Hours: 20:00
Sarepta Therapeutics SG&A Expense (TTM) : 436.74M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 436.74M |
| March 31, 2026 | 467.04M |
| December 31, 2025 | 491.72M |
| September 30, 2025 | 527.29M |
| June 30, 2025 | 563.60M |
| March 31, 2025 | 564.50M |
| December 31, 2024 | 557.87M |
| September 30, 2024 | 525.70M |
| June 30, 2024 | 518.39M |
| March 31, 2024 | 498.16M |
| December 31, 2023 | 481.87M |
| September 30, 2023 | 470.65M |
| June 30, 2023 | 454.54M |
| March 31, 2023 | 490.30M |
| December 31, 2022 | 451.42M |
| September 30, 2022 | 409.00M |
| June 30, 2022 | 365.34M |
| March 31, 2022 | 283.37M |
| December 31, 2021 | 282.66M |
| September 30, 2021 | 290.65M |
| June 30, 2021 | 304.90M |
| March 31, 2021 | 306.24M |
| December 31, 2020 | 317.88M |
| September 30, 2020 | 313.25M |
| June 30, 2020 | 313.31M |
| Date | Value |
|---|---|
| March 31, 2020 | 307.01M |
| December 31, 2019 | 284.81M |
| September 30, 2019 | 267.61M |
| June 30, 2019 | 245.22M |
| March 31, 2019 | 224.99M |
| December 31, 2018 | 207.76M |
| September 30, 2018 | 175.76M |
| June 30, 2018 | 150.89M |
| March 31, 2018 | 139.81M |
| December 31, 2017 | 122.68M |
| September 30, 2017 | 113.40M |
| June 30, 2017 | 107.41M |
| March 31, 2017 | 89.09M |
| December 31, 2016 | 80.62M |
| September 30, 2016 | 82.02M |
| June 30, 2016 | 74.92M |
| March 31, 2016 | 70.10M |
| December 31, 2015 | 75.04M |
| September 30, 2015 | 64.63M |
| June 30, 2015 | 62.42M |
| March 31, 2015 | 61.71M |
| December 31, 2014 | 49.32M |
| September 30, 2014 | 45.80M |
| June 30, 2014 | 40.93M |
| March 31, 2014 | 35.77M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Moderna, Inc. | 965.00M |
| Arrowhead Pharmaceuticals, Inc. | 172.57M |
| Beam Therapeutics, Inc. | 125.40M |
| Twist Bioscience Corp. | 290.29M |
| ImmunityBio, Inc. | 172.60M |